Dermata Therapeutics (NASDAQ:DRMA) just reported results for the second quarter of 2024.
- Dermata Therapeutics reported earnings per share of -$4.18. This was below the analyst estimate for EPS of -$3.79.
- The company did not report any revenue for the quarter.